InMedãMentariãšã®å䜵ã¯11æ6æ¥ã«å®äºèŠèŸŒã¿ã11æ9æ¥ãããMTRIããšããŠNasdaqååŒéå§ãž
ã€ã³ã¡ããã¯ã¡ã³ã¿ãªã»ã»ã©ãã¥ãŒãã£ã¯ã¹ãšã®å䜵ã2026幎11æ6æ¥ã«å®äºããèŠéããšçºè¡šãããå䜵å¥çŽã¯2026幎5æ19æ¥ä»ã®ä¿®æ£èšç»ã«æºæ ãããå幎11æ9æ¥ã®ååŒéå§æãããæ®éæ ªåŒã¯æ°ç€Ÿåããã³æ°ãã£ãã«ãŒãMTRIãã§Nasdaq Capital Marketãžç§»è¡ããæ°ããªCUSIPã»ISINçªå·ãä»äžããããããã«ãå䜵ã«äŒŽãæ¡ä»¶ä»äŸ¡å€æš©ïŒCVRïŒå¥çŽãç· çµããã11æ5æ¥æç¹ã®ç»é²æ ªäž»ã¯ä¿ææ ª1æ ªã«ã€ã1ä»¶ã®CVRãåãåãäºå®ã§ããã
ã€ã³ã¡ããã¯ãå ã«çºè¡šããŠããã¡ã³ã¿ãªã»ã»ã©ãã¥ãŒãã£ã¯ã¹ïŒMentari Therapeutics, Inc.ïŒãšã®å䜵ã«ã€ããŠãæ®ãååŒå®äºæ¡ä»¶ã®å è¶³ãŸãã¯æš©å©æŸæ£ãæ¡ä»¶ãšããŠã2026幎11æ6æ¥ã«å®äºããèŠéãã§ãããšçºè¡šããã
æ¬ååŒã¯ã2026幎5æ19æ¥ä»ã®ä¿®æ£ãããå䜵ããã³çµç¹åç·šèšç»å¥çŽã«æºæ ããŠãããåå¥çŽã®åœäºè ã«ã¯ãå瀟ãã¡ã³ã¿ãªã»ã»ã©ãã¥ãŒãã£ã¯ã¹ãã€ã³ãã£ãŽã»ããŒãžã£ãŒã»ãµãïŒIndigo Merger Sub Corp.ïŒãããã³ã€ã³ãã£ãŽã»ããŒãžã£ãŒã»ãµãIIïŒIndigo Merger Sub II, LLCïŒãå«ãŸããã
2026幎11æ9æ¥ã®ååŒéå§æç¹ãããåç€Ÿã®æ®éæ ªåŒã¯ãMentari Therapeutics, Inc.ãã®ç€Ÿåããã³æ°ããªãã£ãã«ãŒã·ã³ãã«ãMTRIãã§Nasdaq Capital Marketã«ãããŠååŒãéå§ãããèŠèŸŒã¿ã§ããããŸããåæ ªåŒã«ã¯æ°ããªCUSIPçªå·ã587157108ãããã³æ°ããªISINçªå·ãUS5871571080ããä»äžãããäºå®ã§ããã
æ¬å䜵ã«é¢é£ããå瀟ã¯å䜵å®äºæ¥ãŸãã¯ãã以åã«æ¡ä»¶ä»äŸ¡å€æš©ïŒCVRïŒå¥çŽãç· çµããèŠéãã§ããããã®åãæ±ºãã«åºã¥ãã2026幎11æ5æ¥ã®ååŒçµäºæç¹ã«ãããç»é²æ ªäž»ã¯ãä¿æããåç€Ÿã®æ®éæ ªåŒ1æ ªã«ã€ã1ä»¶ã®æ¡ä»¶ä»äŸ¡å€æš©ãåãåãäºå®ã§ããã
ãã®èšäºã®äžéšã¯AIã«ãã£ãŠçæã»ç¿»èš³ããã人éã«ããã¬ãã¥ãŒãçµãŠããŸããããã¯äžè¬çãªæ å ±æäŸã®ç®çã§ã®ã¿äœ¿çšãããŠãããæè³ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸããã
ããããèšäº








ã³ã¡ã³ã (0)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã